Healthcare and Biotech: Is a Turning Point Finally Here?
After several challenging years, the healthcare and biotech sectors may be poised for renewed momentum.
Subtitles: Captioned in the original language and translated into other languages with the help of AI. We accept no liability for any linguistic errors in the translation. Select a language, or turn subtitles on/off, by starting the video and clicking the speech bubble in the bottom right corner.
The healthcare and biotech sectors have faced several challenging years, but recent developments suggest the tide may be turning. In this webinar, Portfolio Manager Rune Sand-Holm joins Jørgen Mørk in our Oslo studio to discuss what has driven the sector’s renewed momentum, why sentiment may be shifting, and where they see the most attractive opportunities going into 2026.
The conversation covers valuation levels, regulatory developments, innovation trends – including the role of artificial intelligence – and a closer look at both large‑cap and small‑ to mid‑cap segments.
This concise update provides timely insights into a sector that may be poised for a stronger year ahead.
Go to the fund-page for more information:
DNB Fund Health Care
Invest in a sector with stability, innovation, and global significance.